Harnessing next-generation sequencing for the management and surveillance of haematological malignancies in the Northern Territory of Australia

Key Points

• To explore the implementation of next-generation sequencing for managing haematological malignancies in the Northern Territory.
• Examined the use of next-generation sequencing for molecular characterisation of acute myeloid leukaemia.
• Identified barriers to access for specialised testing in a geographically isolated region.
• Evaluated the potential to address diagnostic inequities and inequalities.
• Next-generation sequencing significantly enhances the molecular characterisation of acute myeloid leukaemia.
• Improved access can lead to better diagnosis and management of haematological malignancies in isolated regions.